Multiple Sclerosis in Women

Multiple sclerosis (MS) is an autoimmune disorder in which the body’s immune system attacks cells in the brain and spinal cord.1,2 This causes damage to the nervous system that results in neurological symptoms such as vision problems, cognitive issues, numbness, trouble walking, tingling sensations, and incontinence. MS attacks often recur, happening repeatedly over time. Each episode can cause a lingering worsening of symptoms. In some people, MS gets worse slowly without attacks.

Women Are at Higher Risk of Developing MS

While both men and women can develop MS, the disease is much more common in women. In fact, women are two to three times as likely to develop MS than men.3 Furthermore, there are differences in symptoms between men and women living with MS. This is due to a variety of factors, including genetics, hormones, body composition, and environmental factors4.

It is important to note that this article primarily refers to women who were assigned female sex at birth and do not have an intersex condition. Unfortunately, there is limited information about differences in how MS affects transgender or intersex people, who may have hormonal or genetic differences from the cisgender population. However, some evidence suggests that transgender women, who are assigned male sex at birth but identify as women, are more likely to develop MS than cisgender males, whether or not they are on hormone medications.5

Causes of MS in Women

Although scientists have identified many different factors tied to the increased risk of MS in women, the picture is still not entirely clear.3 That’s because we still do not fully understand the cause of MS in men or women. For example, MS is inheritable and commonly occurs in families, but the underlying risk genes are not entirely known.

Similarly, environmental factors like smoking, vitamin D insufficiency, and Epstein-Barr virus infection, which affects 90 percent of adults, are all linked to MS. Environmental factors occurring during pregnancy might be at play as well, as MS risk is linked to birth month.

Why Are Women at Higher Risk for MS? A Closer Look

As previously mentioned, neither the cause of MS nor the reason for the increased risk of MS in women is fully understood.4 However, research has indicated that risk may be increased in women due to genetics, hormone levels, body composition, and environmental factors.

Genetic Factors

Research has shown that people with two X chromosomes have an increased risk of MS, regardless of their hormonal balance.6 Although this would imply that a gene on the X chromosome may be at fault, no single gene on it has been identified that is strongly responsible for MS susceptibility.

Another genetic factor in women is X inactivation.7 During embryonic development, one copy of the X chromosome is randomly shut off in people with two X chromosomes in each cell. Although this is not directly linked to MS risk, some research indicates that this may be tied to whether a woman develops progressive MS or relapsing MS.

Hormonal Factors

Hormones have a strong effect on MS symptoms, although the underlying reason is not entirely clear.3 One possible reason is the effect of hormones on inflammation.


High levels of estrogen or progesterone, two key female sex hormones involved in the menstrual cycle and pregnancy, are linked to a reduction in MS symptoms. As a result, many women have temporary relief from their symptoms during pregnancy, when estrogen levels are high for an extended time.

When hormone levels return to normal after birth, however, some women experience a relapse of their symptoms. Similarly, MS symptoms often worsen after menopause when sex hormone levels drop.


In addition to estrogen and progesterone, testosterone levels may be associated with a reduction in MS occurrence.3 Since testosterone levels are normally much higher in men than women, this could explain the increased levels of MS in women compared to men.

Environmental Factors

There are multiple environmental factors associated with MS.

Vitamin D

Vitamin D is a fat-soluble vitamin that is activated by exposure to sunlight.8 Low vitamin D levels are associated with an increased risk of MS. Accordingly, people in higher latitudes with less intense sunlight tend to have reduced levels of vitamin D and are at higher risk of MS symptoms. Vitamin D is linked to immune function, and research suggests that it is more strongly related to immune function in women.8 As a result, low exposure to sunlight is more associated with MS risk in women than in men.


Tobacco smoking or exposure to tobacco smoke is another factor that increases a person’s chance of developing MS and worsens its symptoms. Smoking may also cause some MS therapies to not work as well.9,10 For this reason and the numerous other negative health effects associated with smoking, it is highly recommended that women with MS avoid smoking and secondhand smoke.

Body Composition

Body composition, in particular body fat, is linked to MS risk and MS symptoms.11 Obesity in childhood increases the risk of subsequently developing MS.12,13

Symptoms of MS in Women

The differences in male and female biology affect the kinds of symptoms that women develop in MS. For example, many women experience worsening MS symptoms during their periods.14 This includes incontinence, vision symptoms, coordination, and movement difficulties.

Some research indicates that hormonal birth control and hormone replacement therapy can soften the impact of menstruation on MS symptoms.14,15 However, any changes to medications must be discussed with your doctor. Fortunately, MS is not known to cause fertility issues.16 Furthermore, the disease is not linked to difficulties with fertility treatments.17


If you are a woman living with MS, you may experience differences in symptoms compared to men with the disease. There are special considerations for the treatment of MS in women, but with an appropriate medication regimen and lifestyle changes, you and your doctors can help manage your symptoms.

Last updated: 08/02/2023Last medically reviewed: 08/01/2023

Medical Disclaimer: The information provided in this article is not a substitute for the advice of qualified healthcare professionals. While we strive to publish accurate information, it is not possible to cover all potential scenarios, including drug or treatment effects, interactions, or usage. You should not rely solely on this article to determine whether a particular treatment, drug, or clinical trial is suitable for you or any other individual. Always consult a healthcare professional before starting or changing any treatments.


  1. Tafti D, Ehsan M, Xixis KL. Multiple Sclerosis. In: StatPearls. Treasure Island (FL). 2023.
  2. Moccia M, Ruggieri S, Ianniello A, Toosy A, Pozzilli C, Ciccarelli O. Advances in spinal cord imaging in multiple sclerosis. Ther Adv Neurol Disord. 2019;12:1756286419840593.
  3. Harbo HF, Gold R, Tintore M. Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord. 2013;6(4):237-248.
  4. Ross L, Ng HS, O'Mahony J, et al. Women's health in multiple sclerosis: A scoping review. Front Neurol. 2021;12:812147.
  5. Pakpoor J, Wotton CJ, Schmierer K, Giovannoni G, Goldacre MJ. Gender identity disorders and multiple sclerosis risk: A national record-linkage study. Mult Scler. 2016;22(13):1759-1762.
  6. Smith-Bouvier DL, Divekar AA, Sasidhar M, et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med. 2008;205(5):1099-1108.
  7. Knudsen GP, Harbo HF, Smestad C, et al. X chromosome inactivation in females with multiple sclerosis. Eur J Neurol. 2007;14(12):1392-1396.
  8. Orton SM, Wald L, Confavreux C, et al. Association of UV radiation with multiple sclerosis prevalence and sex ratio in France. Neurology. 2011;76(5):425-431.
  9. Petersen E, Oturai A, Koch-Henriksen N, et al. Smoking affects the interferon beta treatment response in multiple sclerosis. Neurology. 2018;90(7):e593-e600.
  10. Petersen E, Bach Søndergaard H, Laursen J, et al. Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis. Mult Scler. 2019;25(9):1298-1305
  11. Dionyssiotis Y. Body composition in multiple sclerosis. Hippokratia. 2013;17(1):7-11.
  12. Liu Z, Zhang T, Yu J, et al. Excess body weight during childhood and adolescence is associated with the risk of multiple sclerosis: a meta analysis. Neuroepidemiology. 2016;47(2):103-108. doi:10.1159/000450854
  13. Brenton N, Woolbright E, Briscoe-Abath C, et al. Body mass index trajectories in pediatric multiple sclerosis. Dev Med Child Neurol. 2019;61(11):1289-1294. doi:10.1111/dmcn.14233
  14. Zorgdrager A, De Keyser J. Menstrually related worsening of symptoms in multiple sclerosis. J Neurol Sci. 1997;149(1):95-97.
  15. Smith R, Studd JW. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J R Soc Med. 1992;85(10):612-613.
  16. Coyle PK. What can we learn from sex differences in MS? J Pers Med. 2021;11(10).
  17. Lamaita R, Melo C, Laranjeira C, Barquero P, Gomes J, Silva-Filho A. Multiple sclerosis in pregnancy and its role in female fertility: A systematic review. JBRA Assist Reprod. 2021;25(3):493-499.